Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic Patients Uncontrolled by Diet

NCT00118950 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Metformin
DRUG: Repaglinide
DRUG: Placebo-Metformin.
DRUG: Placebo-Repaglinide.
OTHER: Diet-only.

Sponsor

Steno Diabetes Center Copenhagen